Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CIBAR1 divergent transcript (CIBAR1-DT, LINC00535) is a long non-coding RNA located on chromosome 8 (chr8:93212888-93700512). It is classified as an lncRNA and does not encode a protein[1][3]. The primary molecular function noted is RNA binding, but no protein product or canonical drug target role has been established for this transcript[3]. There are no reported direct disease associations, biomarker roles, or interacting drugs as of the latest gene databases. CIBAR1 divergent transcript is distinct from the protein-coding gene CIBAR1 (CBY1-interacting BAR domain-containing protein 1), which is implicated in ciliogenesis and mitochondrial function, but the divergent transcript itself does not have a confirmed biological or therapeutic relevance in major disease indications[1][3]. In summary, CIBAR1 divergent transcript (LINC00535) is an annotated lncRNA gene with limited functional and clinical evidence, not considered a therapeutic target by standard criteria[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CIBAR1 divergent transcript (CIBAR1-DT).